Silverman Joshua

Silverman Joshua is listed in filings as Director at Petros Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including purchase activity. Recent filings connect the profile to Petros Pharmaceuticals, Inc. (PTPI), TAO Synergies Inc. (TAOX), and PharmaCyte Biotech, Inc. (PMCB). The current snapshot covers public activity from Feb 21, 2025 to Jun 5, 2026. Reported amounts are shown as $960.0K to $23.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.